Clinical Trial Update: An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 open-label, multiple-dose titration study in patients with pulmonary hypertension. Sponsored by Bayer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary | Phase 2 | Status: COMPLETED